Sida 1 från 109 resultat
FIELD OF THE INVENTION
This invention is directed to a method for use of a carbamate compound in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. More particularly, this invention is directed to a method for use of a halogenated 2-phenyl-1,2-ethanediol
This invention relates to a method of treatment of migraine, cluster headaches and trigeminal neuralgia, radiation or cytotoxic agent induced nausea and vomiting and/or cardiac arrhythmia in mammals, including humans, and to the use of compounds in the preparation of a medicament for the treatment
TECHNICAL FIELD
The present disclosure relates to treatment and management of Hypercortisolemia, Headache disorders and Neuropathic pain using a composition comprising asiaticoside and madecasosside optionally along with at least one excipient.
BACKGROUND AND PRIOR ART
Serotonin is a
This invention relates to novel compounds having useful pharmacological properties, to pharmaceutical compositions containing them, to a process and intermediates for their preparation, and to their use as pharmaceuticals.
U.K. Patent Applications, GB Nos. 2100259A and 2125398A describe benzoates
This invention relates to novel compounds having useful pharmacological properties, to pharmaceutical compositions containing them, to a process and intermediates for their preparation, and to their use as pharmaceuticals.
UK Patent Applications, GB Nos. 2100259A and 2125398A describe benzoates and
This invention relates to novel compounds having useful pharmacological properties, to pharmaceutical compositions containing them, to a process and intermediates for their preparation, and to their use as pharmaceuticals.
The compound, N-(1-azabicyclo[2.2.2]oct-3-yl)-2,3-dihydroindole-1-carboxylic
This invention relates to novel compounds having useful pharmacological properties, to pharmaceutical compositions containing them, to a process and intermediates for their preparation, and to their use as pharmaceuticals.
The compound, N-(1-azabicyclo[2 2.2] oct-3-yl)-2,3-dihydroindole-1-carboxylic
FIELD OF THE INVENTION
The present invention relates to a composition and method for the cure of recurring migraine headaches. In particular, the composition and method involves the administration of a combination of dexamethasone, lidocaine, and thiamine to a patient.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a composition and method for the cure of recurring migraine headaches. In particular, the composition and method involves the administration of a combination of dexamethasone, lidocaine, and thiamine to a patient.
BACKGROUND OF THE
BACKGROUND OF THE PRESENT INVENTION
The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,
TECHNICAL FIELD
The present invention relates generally to methods and compositions for the treatment of headache and headache or head pain disorders. More specifically, the present invention relates to methods for the treatment or prevention of primary or secondary headaches by administration of
TECHNICAL FIELD
The present invention relates generally to methods and compositions for the treatment of headache and headache or head pain disorders. More specifically, the present invention relates to methods for the treatment or prevention of primary or secondary headaches by administration of
TECHNICAL FIELD
The present invention relates generally to methods and compositions for the treatment of headache and headache or head pain disorders. More specifically, the present invention relates to methods for the treatment or prevention of primary or secondary headaches by administration of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to medical apparatus and methods. In particular, the present invention relates to methods and devices for delivering carbon dioxide and other gases to patients for relieving symptoms associated with
PRIOR APPLICATION DATA
This application claims priority to and benefit of European Patent Application 10190375.5, filed on Nov. 8, 2010, incorporated by reference herein in its entirety.
FIELD OF THE INVENTION
The present invention relates to a topical preparation containing N-palmitoyl-vanillamide